Table 2: Demography and baseline characteristics of patients.
|
2.5 Million cells/kg |
5 Million cells/kg |
||
Parameter |
Cell (n=10) |
Control (n=10) |
Cell (n=10) |
Control (n=10) |
Male |
10 |
10 |
10 |
10 |
Age (years) |
45.20 ± 8.93 |
44.90 ± 5.63 |
50.90 ± 6.01 |
48.20 ± 8.57 |
Height (cm) |
167.90 ± 7.87 |
167.27 ± 3.80 |
164.62 ± 7.55 |
165.02 ± 5.76 |
Weight (kg) |
64.47 ± 9.85 |
71.64 ± 18.16 |
65.13 ± 13.46 |
59.47 ± 13.14 |
Total Bilirubin (mg/dL) |
3.15 ± 1.12 |
2.84 ± 1.26 |
2.97 ± 2.35 |
2.74 ± 1.73 |
Direct Bilirubin (mg/dL) |
1.31 ± 0.73 |
1.18 ± 0.60 |
1.63 ± 1.65 |
1.59 ± 1.42 |
Total Protiens (g/dL) |
6.49 ± 0.40 |
6.99 ± 0.70 |
7.66 ± 0.52 |
7.40 ± 0.59 |
Serum Albumin (g/dL) |
2.74 ± 0.49 |
2.55 ± 0.303 |
2.70 ± 0.49 |
2.62 ± 0.60 |
Serum Globulin (g/dL) |
3.76 ± 0.54 |
4.44 ± 0.79 |
4.96 ± 0.49 |
4.78 ± 0.70 |
A:G ratio |
0.74 ± 0.26 |
0.59 ± 0.12 |
0.55 ± 0.13 |
0.58 ± 0.22 |
Alanine Aminotransferase (ALT) (U/L) |
43.90 ± 10.96 |
41.90 ± 7.25 |
38.80 ± 10.37 |
46.90 ± 15.48 |
Aspartate Aminotransferase (AST) (U/L) |
68.10 ± 29.57 |
55.20 ± 20.06 |
59.50 ± 24.09 |
63.40 ± 35.74 |
Alkaline Phosphatase (ALP) (U/L) |
172.50 ± 43.22 |
216.70 ± 129.04 |
199.90 ± 143.40 |
222.80 ± 113.69 |
GGT (U/L) |
78.90 ± 66.18 |
118.80 ± 159.37 |
109.90 ± 99.65 |
124.10 ± 166.17 |
Liver Volume (cm3) |
1273.2 ± 424.24 |
1284.7 ± 376.07 |
1038.8 ± 364.10 |
1262.1 ± 486.15 |
MELD Score |
17.00 ± 2.00 |
18.00 ± 6.51 |
16.90 ± 4.15 |
15.00 |
Child-Pugh Score |
9.3 ± 1.25 |
9.2 ± 1.48 |
8.8 ± 1.62 |
9.1 ± 1.45 |
CAP (dB/m) - Fibroscan |
210.1 ± 60.96 |
247.8 ± 48.38 |
213.8 ± 35.69 |
226.0 ± 40.14 |
E(kPa) - Fibroscan |
61.2 ± 18.53 |
61.2 ± 15.32 |
55.3 ± 20.84 |
36.8 ± 33.49 |
Physical component summary (SF-36) |
40.36 ± 7.82 |
38.20 ± 5.73 |
39.45 ± 10.06 |
42.77 ± 4.48 |
Mental component summary (SF-36) |
43.91 ± 8.38 |
46.93 ± 7.64 |
40.05 ± 10.58 |
42.73 ± 5.01 |
Data are expressed as Mean ± SD